Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Administration Newborn (0-1 years) Children (2-9 years) Tuberculosis Diphtheria Tetanus Pertussis Measles
Coverage Ethical issues Parents/caregivers Mumps Measles Rubella
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects All age groups Germany Mumps Measles Pertussis Varicella
Background paper United States of America Human papillomavirus (HPV)
Download:
Background paper United States of America Human papillomavirus (HPV)
Download:
Recommendation Costa Rica Rotavirus
Download:
Agenda & Minutes New Zealand Diphtheria
Download: